美股市場個股詳情
AMRN 阿瑪琳
- 0.918
- +0.079+9.38%
收盤價 05/02 16:00 (美東)
- 0.894
- -0.024-2.61%
盤後 18:07 (美東)
3.77億總市值-7061市盈率TTM
0.930最高價0.813最低價147.87萬股成交量0.813今開0.839昨收130.58萬成交額0.39%換手率虧損市盈率(靜)4.11億總股本1.48552周最高0.69市淨率3.52億流通值0.65152周最低--股息TTM3.83億流通股675.000歷史最高--股息率TTM13.92%振幅0.460歷史最低0.883平均價1股每手
關於阿瑪琳公司
阿瑪琳股份有限公司 是一家生物製藥公司，專注於商業化和開發治療藥物以改善心血管(CV)健康並降低心血管(CV)風險。其商業化產品包括Vascepa。
公司介紹
公司代碼AMRN
公司名稱阿瑪琳
上市日期1993/04/01
發行價格6.00
成立日期1989
CEOMr. Patrick J. Holt
所屬市場納斯達克
員工數量275
證券類型存託憑證（普通股）
ADS轉換比例1.0 : 1.0
年結日12-31
公司地址Iconic Offices, The Greenway,Block C Ardilaun Court, 112–114,St. Stephens Green
城市Dublin
省份都柏林
國家愛爾蘭共和國
郵編2
電話353-1-6699-020
董事高管
- 姓名
- 職務
- 年薪
- Patrick J. Holt
- Director, President and Chief Executive Officer
- 214.37萬
- Jonathan N. Provoost
- Executive Vice President, Chief Legal and Compliance Officer and Secretary
- 65.93萬
- Thomas C. Reilly
- Executive Vice President, Global Head of HR, Chief Financial Officer and Principal Accounting Officer
- 220.20萬
- Dr. Steven B. Ketchum, PhD
- Executive Vice President, President, Research and Development and Chief Scientific Officer
- 235.06萬
- Aaron D. Berg
- Executive Vice President and President, US
- 244.81萬
- Dr. Odysseas D. Kostas, M.D.
- Chairman of the Board
- 65.04萬
- Louis Sterling, III
- Independent Director
- 62.94萬
- Patrice Bonfiglio
- Independent Director
- 62.69萬
- Dr. Paul Cohen, M.D.
- Independent Director
- 62.21萬
- Keith L. Horn
- Independent Director
- 63.21萬
- Diane E. Sullivan
- Independent Director
- 63.08萬
- Oliver O'Connor
- Independent Director
- 61.18萬
- Mark DiPaolo, Esq.
- Independent Director
- 62.10萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅